Thread: Smoking
View Single Post
Old 08-11-2005, 09:32 PM
  # 3 (permalink)  
pedagogue
Member
 
pedagogue's Avatar
 
Join Date: Aug 2004
Location: Anytown, USA
Posts: 1,019
I know the smoking rate for schizophrenics can be as high as 75-85%. There are a number of factors for this which include: chemical benefits, solitary act or social act (depending on the person), etc.

*edit*

The rate is actually 80-90%: http://www.eurekalert.org/pub_releas...-wds021003.php

Nicotine produces rewarding and aversive motivational effects in humans and other animal species. Here, the authors report that the mammalian ventral tegmental area (VTA) represents a critical neural substrate for the mediation of both the rewarding and aversive properties of nicotine. They demonstrate that direct infusions of nicotine into the VTA can produce both rewarding and aversive motivational effects. While the rewarding effects of higher doses of nicotine were not attenuated by dopamine (DA) receptor blockade, blockade of mesolimbic DA signalling with either systemic or intra-nucleus accumbens (NAc) neuroleptic pretreatment potentiated the sensitivity to nicotine's rewarding properties over a three-order-of-magnitude dose range. Furthermore, the behavioural effects of lower doses of intra-VTA nicotine were reversed, switching the motivational valence of nicotine from aversive to rewarding. These results suggest that blockade of mesolimbic DA signalling induced by neuroleptic medications may block selectively the aversive properties of nicotine, thus increasing the vulnerability to nicotine's rewarding and addictive properties by inducing a unique, drug-vulnerable phenotype.

Citation source: Molecular Psychiatry 2003 Volume 8, number 1, pages 50-59.


The author is pretty much saying that because of the type of medication a schizophrenic would be on (nueroleptic), the 'good' effects of the nicotine are better realized because the adverse effects would be lessened or suppressed.

-pedagogue
pedagogue is offline